Effect of Genetic Variation of IL-13 on Airway Remodeling in Bronchial Asthma
IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a posit...
Saved in:
Published in | Allergology International Vol. 60; no. 3; pp. 291 - 298 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier B.V
2011
JAPANESE SOCIETY OF ALLERGOLOGY Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1323-8930 1440-1592 1440-1592 |
DOI | 10.2332/allergolint.10-OA-0259 |
Cover
Abstract | IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population.
A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined.
Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker.
Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. |
---|---|
AbstractList | Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. Methods: A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Results: Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Conclusions: Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population.BACKGROUNDIL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population.A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined.METHODSA total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined.Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker.RESULTSForced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker.Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function.CONCLUSIONSOur study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. [ABSTRACT] Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. Methods: A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Results: Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Conclusions: Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are associated with allergic phenotypes in several ethnically diverse populations. In particular, IL13Q110 is the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 110 of IL-13, and as we already know, individuals homozygous for glutamine (Q110/Q110) are strongly associated with asthma and IgE. IL13Q110 has been demonstrated to show that increased allergic inflammation depended on the enhanced IL-13-mediated Th2 effector function. Therefore, we investigated whether Q110/Q110 accelerated the decline in pulmonary function and development of airway remodeling of asthmatic patients in the general population. A total 336 asthmatic subjects living in Japan were recruited, genotyped, and had a pulmonary function test performed on them. To analyze airway inflammation and remodeling, bronchial lavage fluid (BLF) and endobronchial biopsy specimens were examined. Forced expiratory volume in one second (FEV1), %predicted, forced expiratory volume/forced vital capacity ratio, and forced expiratory flow 25-75%, % predicted were significantly decreased in Q110/Q110 compared to R110/R110, and the decline in FEV1 was increased significantly in Q110/Q110 compared to R 110/R110. The concentration of IL-13, IL-23, IL-11, GM-CSF, hyaluronic acid, and CCL8 in BLF were increased in Q110/Q110 compared to R110/R110 and the thickness of the subepithelial layer was thicker. Our study demonstrates that Q110/Q110 increases, at least in part, allergic inflammation and the propensity for airway remodeling, thus resulting in low lung function. |
Author | Sawai, Takashi Yamauchi, Kohei Nakamura, Yutaka Inoue, Hiroshi Nagashima, Hiromi Kanno, Hiroyuki |
Author_xml | – sequence: 1 givenname: Hiromi surname: Nagashima fullname: Nagashima, Hiromi email: ICB75097@nifty.com organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan – sequence: 2 givenname: Yutaka surname: Nakamura fullname: Nakamura, Yutaka organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan – sequence: 3 givenname: Hiroyuki surname: Kanno fullname: Kanno, Hiroyuki organization: Division of Leading Pathophysiology, Department of Pathology, Iwate Medical University School of Medicine,Iwate, Japan – sequence: 4 givenname: Takashi surname: Sawai fullname: Sawai, Takashi organization: Division of Leading Pathophysiology, Department of Pathology, Iwate Medical University School of Medicine,Iwate, Japan – sequence: 5 givenname: Hiroshi surname: Inoue fullname: Inoue, Hiroshi organization: Iwate Red Cross Blood Center, Iwate, Japan – sequence: 6 givenname: Kohei surname: Yamauchi fullname: Yamauchi, Kohei organization: Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine,Iwate, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21430433$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQjVAR_YC_UOXGKWXsSRxb4sBSlWWlRSsh4Go5zmTrVdYuTrZV_z3OplSISy-e0fi9N-N5Ps9OfPCUZZcMrjgi_2D6nuI29M6PVwyKzaIAXqlX2RkrSyhYpfhJypFjIRXCaXY-DDsAxmtVv8lOOSsRSsSz7NtN15Ed89DlS_I0Opv_MtGZ0QU_FVfrgmGe8oWLD-Yx_0770FJqu82dzz_H4O2tM32-GMbbvXmbve5MP9C7p3iR_fxy8-P6a7HeLFfXi3VhhapUUZLCRgKzAutOpLkZs5wstgRkLAITZcdZ03SykhYr0bESbLqoFW9rJTheZKtZtw1mp--i25v4qINx-lgIcatNTG_pSTdM2LbhoGRtygqbRkhE0dUSmYDW1Enr_ax1F8PvAw2j3rvBUt8bT-EwaCkrrgBKmZCXT8hDs6f2ue_fbSaAmAE2hmGI1D1DGOjJNv2PbVNts9CTbYn48T-idePRgzEa179MX870NJWzpg8-IUjvwiH6ZIO2D6U5cjgwpgEEAKYgE1ux6ZCsQgYwLfbTrETJvXtHUQ_WkbdJN6ZvktbrXhrmD0UOzMw |
CitedBy_id | crossref_primary_10_1016_j_jbiomech_2016_12_002 crossref_primary_10_3389_falgy_2024_1365801 crossref_primary_10_1371_journal_pone_0188407 crossref_primary_10_1111_crj_12647 crossref_primary_10_1016_j_resinv_2013_02_003 crossref_primary_10_1186_s12931_023_02528_w crossref_primary_10_1016_j_alit_2015_01_001 crossref_primary_10_1016_j_bbadis_2020_165950 crossref_primary_10_3389_fimmu_2017_01172 crossref_primary_10_1111_cea_12710 crossref_primary_10_2332_allergolint_12_OA_0528 crossref_primary_10_1016_j_intimp_2015_08_043 crossref_primary_10_1016_j_smim_2019_101346 crossref_primary_10_4168_aair_2019_11_5_604 |
Cites_doi | 10.1164/ajrccm.151.6.7767540 10.1067/mai.2002.124656 10.1172/JCI200522818 10.1016/j.jaci.2003.10.044 10.1093/hmg/9.4.549 10.1067/mai.2000.107935 10.4049/jimmunol.174.4.2305 10.1016/S0091-6749(98)70018-1 10.1172/JCI17748 10.4049/jimmunol.177.12.8633 10.1056/NEJM200010123431501 10.1165/rcmb.2002-0009OC 10.1164/ajrccm/140.6.1745 10.1136/thx.53.1.21 10.1016/j.rmed.2005.02.027 10.1016/j.jaci.2008.02.029 10.1164/rccm.200801-086OC 10.1164/ajrccm.160.2.9809040 10.1016/S0140-6736(89)90067-6 10.1183/09031936.03.00082002 10.1067/mai.2001.115626 10.1046/j.1365-2222.1998.00277.x 10.1164/ajrccm.156.2.9609066 10.1016/S0091-6749(00)90070-8 10.1016/j.jaci.2005.12.1354 10.1136/thx.53.10.835 10.1038/sj.gene.6363896 10.1016/0091-6749(91)90408-G 10.1067/mai.2000.104940 |
ContentType | Journal Article |
Copyright | 2011 Japanese Society of Allergology |
Copyright_xml | – notice: 2011 Japanese Society of Allergology |
CorporateAuthor | Allergy Department of Pathology Department of Internal Medicine Iwate Red Cross Blood Center Division of Leading Pathophysiology Division of Pulmonary Medicine Iwate Medical University School of Medicine and Rheumatology |
CorporateAuthor_xml | – name: Department of Pathology – name: Allergy – name: Division of Leading Pathophysiology – name: Division of Pulmonary Medicine – name: and Rheumatology – name: Iwate Medical University School of Medicine – name: Iwate Red Cross Blood Center – name: Department of Internal Medicine |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.2332/allergolint.10-OA-0259 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1592 |
EndPage | 298 |
ExternalDocumentID | oai_doaj_org_article_b16cdb20987a453bb68336f783160da7 21430433 10_2332_allergolint_10_OA_0259 cw4alint_2011_006003_008_0291_02981531002 S132389301530530X |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 0R~ 0SF 1OC 23M 2WC 31~ 4.4 457 53G 5GY 5VS 6I. 7.U 8-1 AACTN AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFO ACGFS ACXQS ADBBV ADEZE AENEX AEXQZ AFTJW AFZJQ AGHFR AHPSJ AITUG AJAOE ALMA_UNASSIGNED_HOLDINGS AMRAJ AZFZN BAWUL BCNDV BFHJK CAG CO8 COF CS3 DIK E3Z EBS EJD F5P FDB FRJ GROUPED_DOAJ GX1 HZ~ IPNFZ JSF JSH KQ8 LH4 LW6 M41 NCXOZ O9- OK1 P2P P6G RIG RJT RNS ROL RZJ SSZ TKC TR2 X7M YFH YUY AAYWO ACVFH ADCNI ADVLN AEUPX AFPUW AIGII AKBMS AKRWK AKYEP OVT AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c6959-4e93b801c637f625911c2ec3de0eac30164f21bbf858c356f140cac3792d79623 |
IEDL.DBID | DOA |
ISSN | 1323-8930 1440-1592 |
IngestDate | Wed Aug 27 01:17:07 EDT 2025 Thu Jul 10 17:11:10 EDT 2025 Thu Jan 02 22:10:21 EST 2025 Tue Jul 01 04:11:24 EDT 2025 Thu Apr 24 22:53:43 EDT 2025 Thu Jul 10 16:16:36 EDT 2025 Fri Feb 23 02:29:20 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | bronchial asthma bronchial lavage fluid IL-13 polymorphisms bronchial biopsy |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 http://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c6959-4e93b801c637f625911c2ec3de0eac30164f21bbf858c356f140cac3792d79623 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/b16cdb20987a453bb68336f783160da7 |
PMID | 21430433 |
PQID | 885290048 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b16cdb20987a453bb68336f783160da7 proquest_miscellaneous_885290048 pubmed_primary_21430433 crossref_primary_10_2332_allergolint_10_OA_0259 crossref_citationtrail_10_2332_allergolint_10_OA_0259 medicalonline_journals_cw4alint_2011_006003_008_0291_02981531002 elsevier_sciencedirect_doi_10_2332_allergolint_10_OA_0259 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-00-00 |
PublicationDateYYYYMMDD | 2011-01-01 |
PublicationDate_xml | – year: 2011 text: 2011-00-00 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Allergology International |
PublicationTitleAlternate | Allergol Int |
PublicationYear | 2011 |
Publisher | Elsevier B.V JAPANESE SOCIETY OF ALLERGOLOGY Elsevier |
Publisher_xml | – name: Elsevier B.V – name: JAPANESE SOCIETY OF ALLERGOLOGY – name: Elsevier |
References | Belperio (10.2332/allergolint.10-OA-0259_bb0040) 2002; 27 Liu (10.2332/allergolint.10-OA-0259_bb0110) 2000; 106 The Childhood Asthma Management Program Research Group (10.2332/allergolint.10-OA-0259_bb0150) 2000; 343 Hoshino (10.2332/allergolint.10-OA-0259_bb0020) 2001; 107 Hoffjan (10.2332/allergolint.10-OA-0259_bb0050) 2004; 113 Nakamura (10.2332/allergolint.10-OA-0259_bb0080) 1998; 53 Hoshino (10.2332/allergolint.10-OA-0259_bb0010) 1998; 53 Roche (10.2332/allergolint.10-OA-0259_bb0025) 1989; 1 Vignola (10.2332/allergolint.10-OA-0259_bb0090) 1997; 156 Hoshino (10.2332/allergolint.10-OA-0259_bb0100) 1998; 28 Elias (10.2332/allergolint.10-OA-0259_bb0035) 2003; 111 Kay (10.2332/allergolint.10-OA-0259_bb0005) 1991; 87 Wakashin (10.2332/allergolint.10-OA-0259_bb0125) 2008; 178 Vladich (10.2332/allergolint.10-OA-0259_bb0120) 2005; 115 van der Pouw Kraan (10.2332/allergolint.10-OA-0259_bb0045) 2002; 3 Takishima (10.2332/allergolint.10-OA-0259_bb0075) 1981; 80 Busse (10.2332/allergolint.10-OA-0259_bb0145) 2008; 121 Minshall (10.2332/allergolint.10-OA-0259_bb0130) 2000; 105 Hoshino (10.2332/allergolint.10-OA-0259_bb0095) 1998; 102 Jeffery (10.2332/allergolint.10-OA-0259_bb0030) 1989; 140 Cameron (10.2332/allergolint.10-OA-0259_bb0055) 2006; 177 Maier (10.2332/allergolint.10-OA-0259_bb0060) 2006; 117 Huang (10.2332/allergolint.10-OA-0259_bb0015) 1999; 160 Arima (10.2332/allergolint.10-OA-0259_bb0070) 2002; 109 Takahashi (10.2332/allergolint.10-OA-0259_bb0085) 2005; 99 Woolley (10.2332/allergolint.10-OA-0259_bb0140) 1995; 151 Graves (10.2332/allergolint.10-OA-0259_bb0115) 2000; 105 Heinzmann (10.2332/allergolint.10-OA-0259_bb0065) 2000; 9 Chen (10.2332/allergolint.10-OA-0259_bb0135) 2005; 174 Hoshino (10.2332/allergolint.10-OA-0259_bb0105) 2003; 21 |
References_xml | – volume: 151 start-page: 1915 year: 1995 ident: 10.2332/allergolint.10-OA-0259_bb0140 article-title: Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.151.6.7767540 – volume: 109 start-page: 980 year: 2002 ident: 10.2332/allergolint.10-OA-0259_bb0070 article-title: Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2002.124656 – volume: 80 start-page: 600 year: 1981 ident: 10.2332/allergolint.10-OA-0259_bb0075 article-title: Direct-writing recorder of the dose–response curves of the airway to methacholine publication-title: Clinical application. Chest – volume: 115 start-page: 747 year: 2005 ident: 10.2332/allergolint.10-OA-0259_bb0120 article-title: IL-13R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation publication-title: J Clin Invest doi: 10.1172/JCI200522818 – volume: 113 start-page: 511 year: 2004 ident: 10.2332/allergolint.10-OA-0259_bb0050 article-title: Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2003.10.044 – volume: 9 start-page: 549 year: 2000 ident: 10.2332/allergolint.10-OA-0259_bb0065 article-title: Genetic variants of IL-13 signalling and human asthma and atopy publication-title: Hum Mol Genet doi: 10.1093/hmg/9.4.549 – volume: 106 start-page: 167 year: 2000 ident: 10.2332/allergolint.10-OA-0259_bb0110 article-title: An IL-13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90) publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2000.107935 – volume: 174 start-page: 2305 year: 2005 ident: 10.2332/allergolint.10-OA-0259_bb0135 article-title: IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling publication-title: J Immunol doi: 10.4049/jimmunol.174.4.2305 – volume: 102 start-page: 783 year: 1998 ident: 10.2332/allergolint.10-OA-0259_bb0095 article-title: Bronchial subepithelial fibrosis and expression of matrix metalloproteinsas-9 in asthmatic airway inflammation publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(98)70018-1 – volume: 111 start-page: 291 year: 2003 ident: 10.2332/allergolint.10-OA-0259_bb0035 article-title: New insights into the pathogenesis of asthma publication-title: J Clin Invest doi: 10.1172/JCI17748 – volume: 177 start-page: 8633 year: 2006 ident: 10.2332/allergolint.10-OA-0259_bb0055 article-title: Th2 cell-selective enhancement of human IL13 transcription by IL 13-1112C>T, a polymorphism associated with allergic inflammation publication-title: J Immunol doi: 10.4049/jimmunol.177.12.8633 – volume: 343 start-page: 1054 year: 2000 ident: 10.2332/allergolint.10-OA-0259_bb0150 article-title: Long-term effects of budesonide or nedocromil in children with asthma publication-title: N Engl J Med doi: 10.1056/NEJM200010123431501 – volume: 27 start-page: 419 year: 2002 ident: 10.2332/allergolint.10-OA-0259_bb0040 article-title: Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2002-0009OC – volume: 140 start-page: 1745 year: 1989 ident: 10.2332/allergolint.10-OA-0259_bb0030 article-title: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/140.6.1745 – volume: 53 start-page: 21 year: 1998 ident: 10.2332/allergolint.10-OA-0259_bb0010 article-title: Expression of growth factors and remodelling of the airway wall in bronchial asthma publication-title: Thorax doi: 10.1136/thx.53.1.21 – volume: 99 start-page: 1125 year: 2005 ident: 10.2332/allergolint.10-OA-0259_bb0085 article-title: Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome publication-title: Respir Med doi: 10.1016/j.rmed.2005.02.027 – volume: 121 start-page: 1167 year: 2008 ident: 10.2332/allergolint.10-OA-0259_bb0145 article-title: The Inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2008.02.029 – volume: 178 start-page: 1023 year: 2008 ident: 10.2332/allergolint.10-OA-0259_bb0125 article-title: IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200801-086OC – volume: 160 start-page: 725 year: 1999 ident: 10.2332/allergolint.10-OA-0259_bb0015 article-title: Enhanced proteoglycan deposition in the airway wall of atopic asthmatics publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.160.2.9809040 – volume: 1 start-page: 520 year: 1989 ident: 10.2332/allergolint.10-OA-0259_bb0025 article-title: Subepithelial fibrosis in the bronchi of asthmatics publication-title: Lancet doi: 10.1016/S0140-6736(89)90067-6 – volume: 21 start-page: 804 year: 2003 ident: 10.2332/allergolint.10-OA-0259_bb0105 article-title: Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma publication-title: Eur Respir J doi: 10.1183/09031936.03.00082002 – volume: 107 start-page: 1034 year: 2001 ident: 10.2332/allergolint.10-OA-0259_bb0020 article-title: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.115626 – volume: 28 start-page: 568 year: 1998 ident: 10.2332/allergolint.10-OA-0259_bb0100 article-title: Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma publication-title: Clin Exp Allergy doi: 10.1046/j.1365-2222.1998.00277.x – volume: 156 start-page: 591 year: 1997 ident: 10.2332/allergolint.10-OA-0259_bb0090 article-title: Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.156.2.9609066 – volume: 105 start-page: 232 year: 2000 ident: 10.2332/allergolint.10-OA-0259_bb0130 article-title: IL-11 expression is increased is severe asthma: association with epithelial cells and eosinophils publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(00)90070-8 – volume: 117 start-page: 1306 year: 2006 ident: 10.2332/allergolint.10-OA-0259_bb0060 article-title: Association of IL 13 with total IgE: evidence against an inverse association of atopy and diabetes publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.12.1354 – volume: 53 start-page: 835 year: 1998 ident: 10.2332/allergolint.10-OA-0259_bb0080 article-title: Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma publication-title: Thorax doi: 10.1136/thx.53.10.835 – volume: 3 start-page: 436 year: 2002 ident: 10.2332/allergolint.10-OA-0259_bb0045 article-title: Chronic obstructive pulmonary disease is associated with the −1055 IL-13 promoter polymorphism publication-title: Genes Immun doi: 10.1038/sj.gene.6363896 – volume: 87 start-page: 893 year: 1991 ident: 10.2332/allergolint.10-OA-0259_bb0005 article-title: Asthma and inflammation publication-title: J Allergy Clin Immunol doi: 10.1016/0091-6749(91)90408-G – volume: 105 start-page: 506 year: 2000 ident: 10.2332/allergolint.10-OA-0259_bb0115 article-title: A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2000.104940 |
SSID | ssj0012797 ssib044728993 ssib050995378 ssib001508366 |
Score | 1.9458914 |
Snippet | IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13 are... [ABSTRACT] Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide... Background: IL-13 is a major stimulator of inflammation and tissue remodeling at sites of Th2 inflammation, and common single-nucleotide polymorphisms in IL13... |
SourceID | doaj proquest pubmed crossref medicalonline elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 291 |
SubjectTerms | Adult Aged Airway Remodeling - genetics Asthma - genetics Asthma - immunology Asthma - pathology bronchial asthma bronchial biopsy bronchial lavage fluid Bronchoalveolar Lavage Fluid - chemistry Bronchoalveolar Lavage Fluid - immunology Female Fibroblasts - metabolism Gene Expression Profiling Genetic Predisposition to Disease Genetic Variation Genotype Humans IL-13 Inflammation Mediators - metabolism Interleukin-13 - genetics Male Middle Aged polymorphisms Respiratory Mucosa - pathology |
Title | Effect of Genetic Variation of IL-13 on Airway Remodeling in Bronchial Asthma |
URI | https://dx.doi.org/10.2332/allergolint.10-OA-0259 http://mol.medicalonline.jp/library/journal/abstract?GoodsID=cw4alint/2011/006003/008&name=0291-0298e https://www.ncbi.nlm.nih.gov/pubmed/21430433 https://www.proquest.com/docview/885290048 https://doaj.org/article/b16cdb20987a453bb68336f783160da7 |
Volume | 60 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9ygggifttTjzz4GjZN0iZ5uyp3nJ7rweHpvYUkTXXB68ruHocv_u3ONN3l9kH2RSihpOnXZNL5TZP5DSFvjTTaVEoxqYRiKrWCeRFLFpXVyfOO84CBwtPP9cmF-nhZXd5K9YVrwjI9cBbcJJR1bIPg4Bt7VckQaiNl3Wkjy5q3fogj55avnalx_kDonFZFCsnAIvMcGyykFBNMUbL4jhlxkD2anTUMzL7dMksDe_-WdXpwladNMn3Fv9HoYJWOH5GHI5ykTX6Nx-RO6p-Qe9NxwvwpmWZ2YjrvKBJMQyv6FbzjoTuw8sMnVkoK-81sceN_0_M0pMYBe0ZnPQUfvce10HCD5erHlX9GLo6Pvrw_YWMGBRZr_L-nkpUBbFCspe7Q0ynLKFKUbeLwwZVIr9WJMoTOVCbKqu7A3YpwQFvRagvI6DnZ6-d9ekmo1Rg0K7XmbauCrL2MURmMMvSAMpIvSLUWoIsjvThmufjpwM1Awbtbgse6s8ah4Asy2Zz3KxNs7DzjHfbPpjUSZA8VoDZuVBu3S20KYte960askTEEXGq28wEOt9TBjcN-6eKN8kNjhFUOuW64dEOeT2FLLAwYGCS9LQhda5CD8YyTNL5P8-ulM6YSFr-rBXmRNWvzogKwLfLN7f8PAbwi9_Pvcdxek73V4jq9AXy1CgfkbnN6_u30YBhSUE7_HP0FoeYflg |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Genetic+Variation+of+IL-13+on+Airway+Remodeling+in+Bronchial+Asthma&rft.jtitle=Allergology+international&rft.au=Nagashima%2C+Hiromi&rft.au=Nakamura%2C+Yutaka&rft.au=Kanno%2C+Hiroyuki&rft.au=Sawai%2C+Takashi&rft.date=2011&rft.pub=Elsevier+B.V&rft.issn=1323-8930&rft.eissn=1440-1592&rft.volume=60&rft.issue=3&rft.spage=291&rft.epage=298&rft_id=info:doi/10.2332%2Fallergolint.10-OA-0259&rft.externalDocID=S132389301530530X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-8930&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-8930&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-8930&client=summon |